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ABSTRACT
Introduction: Acne vulgaris is not only associated with physical morbidity, but also associated with significant psy-
chosocial disturbances, such as depression and suicide.  The objective of this study was to examine the functional 
disability and psychological impact of acne vulgaris. Methods: A cross-sectional study of 55 acne patients, aged 
more than 12, was conducted in the dermatology clinic of Serdang Hospital from January to March 2017. Data on 
demographics, clinical features, current treatment modalities were collected. Acne severity was graded using Com-
prehensive Acne Severity Scale (CASS), Cardiff Acne Disability Index (CADI) was used to assess functional disability, 
while DASS-21 was used to assess three related states of depression, anxiety and stress. Statistical analysis was done 
using SPSS software. A p value ≤ 0.05 considered significant. Results: The mean age was 23.2 (14-46), majority were 
females (39, 70.9%), Malays (44, 80%) and students (34, 61.8%). 53 (96.4%) subjects had almost clear (CASS = 1) to 
moderate (CASS = 3) acne severity. Majority had facial acne with or without truncal involvement, 53 (96.3%). The 
average age of disease onset was 17.8 (9-45). 45 (81.8%) patients found their acne mild to moderately disabling. 
69.1%, 45.8% and 41.8% reported feeling anxious, depressed and stressed out. CADI was found to be significantly 
related with depression (p=0.012), anxiety (p= 0.015) and stress (p=0.001). Relationship between CASS with CADI 
(p=0.07), stress (p=0.09), anxiety (p=0.13) and depression (p=0.12) were insignificant. Conclusion: Although acne 
vulgaris is not hazardous, it is associated with psychosocial disturbances. Early and effective treatments are neces-
sary, especially when dealing with facial lesions. 
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INTRODUCTION
Acne vulgaris (AV) is a chronic disease due to 
inflammation of the pilosebaceous unit. It was named 
as the eighth most prevalent disease worldwide (1). 
AV affects 85% of young adults aged 12-25 years. 
In 2004, over 2.2 billion U.S dollars had been used 
for acne treatment in United States (2). The disease 
is characterized by the inappropriate keratinization 
of follicular epithelium which subsequently causes 
obstructive and inflammatory lesions. Proliferation 
of Propionibacterium acnes also contributed to the 
pathogenesis of acne. Although clearance occurs mostly 
before 25 years of age, acne lesion can persist into 
middle age for both sexes (3). Acne have a wide range 
of potential harm and associated cost. This includes 
physical discomfort, scarring, psychosocial distress, 
and potential psychiatric diseases, such as depression 
and suicide (4). Dermatologic patients experience 
psychologic symptoms more commonly than healthy 
people without skin diseases. Psychosomatics may 
play a part in the pathogenesis of AV (5). It has 
been speculated that stress could upregulate sebum 
production via substance P receptors, causing an AV 
flare (6). The objective of the study is to examine the 
functional disability and psychological impact of acne 
vulgaris among patients who attended dermatology 
outpatient clinic in Hospital Serdang, Malaysia. 
MATERIALS AND METHODS
This cross-sectional, questionnaire-based study was 
done in 55 consenting patients, aged 12 and above, 
who attended the Dermatology outpatient clinic of 
Serdang Hospital, Malaysia from January 2017 to 
March 2017. Patients with other forms of acne (acne 
conglobate, acne mechanica, acneiform eruption of any 
causes) were excluded. As this was a study meant to be 
a pilot screening purpose in our clinic setting, no proper 
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sample size calculation was done.
A detailed history pertaining to the demographics, clinical 
features, current treatment modalities were elicited. A 
thorough dermatological examination was performed 
to grade the acne severity according to Comprehensive 
Acne Severity Scale (CASS). Cardiff Acne Disability 
Index (CADI) (7) was used to assess functional disability, 
while 21 item version of Depression Anxiety and Stress 
Scales (DASS-21) was used to assess three related states 
of depression, anxiety and stress. 
CADI is a validated, self-reported questionnaire. It 
consists of five questions with a Likert scale and four 
response categories (0-3). The five questions relate to 
feelings, social life and relationships, skin exposures, 
overall severity. The final score ranges from 0 to 15. 
The higher score implied a higher level of functional 
impairment. We graded the level of impairment as 
mild (0-5), moderate (6-10) and severe (11-15) as 
per previously published (8). Permission to use this 
questionnaire was granted by Professor Andrew Y 
Finlay (License ID CUQoL136). An English version and 
translated Bahasa Malaysia version were used in this 
study. 
CASS is an assessment tool to assess severity of facial 
acne. It significantly correlates with the Leed’s technique 
for assessment of facial, and truncal acne. However, it 
appears to be a simpler method to be used in clinical 
practice. The assessment was done at a distance of 2.5 
meters away from acne on face, chest and back. The 
severity of each region is graded on a 0 to 5 scale (9). 
DASS is a screening tool to assess symptoms of 
depression, anxiety and stress. This instrument consists 
of three sub-scales, namely depression, anxiety and 
stress. In the depression sub-scale, hopelessness, low 
left esteem, and low positive affect were measured. 
Autonomic arousal, musculoskeletal symptoms, 
situational anxiety and subjective experience of anxious 
arousal were assessed in the anxiety subscale. Tension, 
agitation and negative affect were otherwise measured 
in the stress subscale. DASS consist of 2 versions, that 
are the full 42-item and the short 21-item versions. 21 
item version of DASS (DASS-21) is easier to be used in 
clinical setting, and thus opted to be used in our study. 
Both validated English and Malay version had been 
used.  
SPSS version 22 (SPSS Inc., Chicago, IL, USA) was used to 
analyzed collected data. Categorical data were asserted 
as frequencies and percentages. Continuous data were 
reported as either means with standard deviations or 
median with interquartile range. Fisher-exact test was 
used to investigate categorical data. A p value of < 0.05 
was deemed significant. 
 
RESULTS
Demographic data
A total of 55 patients (16 males, 39 females; 29.1% and 
70.9%, respectively) were enrolled in the study (Table 
I). The median age was 23 (range: 17-28). Ethnic groups 
of the cohort included, Malay, 44 (80%); Chinese, 10 
(18.2%) and Indian, 1 (1.8%).
Table I: Demographic and clinical features of the study population
Demographic Frequency 
Gender (M:F) 1:1.89 (16:39)
Race Malay 44 (80%)
Chinese 10 (18.2%)
Indian 1 (1.8%)
Median Age 23 (range: 17-28 years old)
Lesion Type Comedonal 39, (70.9%)
Papule 47, (85.5%)
Pustules 31, (56.4%)
Nodular 6, (10.9)
Cystic 2, (3.6%)
Severity Almost Clear 9 (16.4%)
Mild 20 (36.4%)
Moderate 24 (43.6%)
Severe 1 (1.8%)
Very Severe 1 (1.8%)
Treatment LA Antimicrobial 40 (72.7%)
LA Retinoids 22 (40%)
Combination 2 (3.6%)
Azelaic acid 1 (1.8%)
Sulphur 5 (9.1%)
PO Antibiotic 25 (45.5%)
PO Isotretinoin 9 (16.4%)
CAM 2 (3.6%)
Not on treatment 7 (12.7%)
Area affected Face 30 (54.5%)
Trunk 2 (3.6%)
Face & Trunk 23 (41.8%)
*LA: local application; PO: per oral; CAM: complementary & alternative medicine
Acne severity
Overall, patient with almost clear to mild acne was seen 
in 29 patients (52.8%); moderate acne was seen in 24 
(43.6%), and severe to very severe acne was seen in 2 
patients (3.6%). Although female patients comprised 
of 70.9% of the study population, only 35.9% were 
having moderate to severe acne. In comparison to the 
male patients, 75.1% them who sought treatment were 
having moderate to severe acne (Figure 1).
Site of distribution
Majority had facial acne with or without truncal 
involvement, 53 (96.3%). Out of this, 23 (41.8%) had 
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Figure 1: Severity of acne in according to gender
both facial and truncal involvement while remaining 
had pure facial involvement 30 (54.5%). Only 2 patients 
had pure truncal acne. 
Age of acne onset and duration of acne
76.4% of the patients had an onset of acne between 11-
20 years old. 21.9% had acne onset after the age of 21, 
while the remaining are before the age of ten. 96.4% of 
the patients had acne duration of less than 18 months, in 
which 70.9% presented during the first 6 months of acne 
onset, while 16.4% presented before 1 year of onset. 
Treatment received 
40 (72.7%) received topical benzoyl peroxide, 22 (40%) 
received topical tretinoin, 25 (45.5%) received oral 
antibiotics and 9 (16.4%) received oral isotretinoin, as 
the treatment for AV. 
Functional disability 
The mean CADI score was 7 ± 3.72. Recorded impairment 
levels included: mild, 19 (34.5%); moderate, 26 patients 
(47.3%); and severe, 10 patients (18.2%) (Table II). The 
mean score of the question were: feeling of aggression 
(Q1), 1.53 ± 1.00; interference with social life (Q2), 
1.29 ± 1.00; avoidance of public changing facilities 
(Q3), 0.84 ± 1.10; appearance of the skin all over the 
last month (Q4), 1.71 ± 0.88; and indication of how bad 
the acne is now (Q5), 1.64 ± 0.85. 
Table II: Result of functional disability using CADI©
Q1 Q2 Q3 Q4 Q5 Total
Mean ± 
SD
1.53 ± 
1.00
1.29 ± 
1.00
0.84 ± 
1.10
1.71 ± 
0.88
1.64 ± 
0.85
7 ± 
3.72
Psychological morbidity
Less than half of the patients reported symptoms of 
depression (45.5%) and stress (41.8%). Out of the 
patients who reported symptoms of depression, 7 patients 
(12.7%) had moderate symptoms, while 4 (7.3%) and 2 
(3.6%) reported severe and extremely severe depression. 
Among latter, only 2 had physician graded severe and 
extremely severe acne. 3 of them were treated with 
isotretinoin (Figure 2).
69.1% of the patients reported symptoms of anxiety. 
Out of this group of patients, 13 (23.6%) and 11 (20%) 
patients reported mild and moderate anxiety symptoms. 
The remaining falls in to the group of severe and 
extremely severe anxiety, in which each have 9 (16.4%) 
and 5 (9.1%) each.  6 patients (16.4%) were reported 
having moderate stress, while 7 (12.7%) and one (1.8%) 
falls into the range of severe and extremely severe stress 
range. 
Factors associated with functional disability and 
psychological impact
CADI was found to be significantly related with 
depression (p=0.012), anxiety (p= 0.015) and stress 
(p=0.001). No significant relationship was found 
between sex and ethnicity with CADI (p= 0.345, 
and p=0.800, respectively). We found no significant 
relationship between gender or CASS with DASS. There 
was no significant relationship between CASS and CADI 
(p=0.182).
DISCUSSION
In our study, near 80% of the patients have an age of 
acne onset between the age of 11-20 years old. This is 
consistent with the finding that 85% of the age of acne 
onset is between the age of 12-24 years old (10). This 
is most likely due to hormonal surge before and during 
puberty. Male patients who seek dermatology consult 
have more severe acne. Similar finding is shown in 
several other community based studies (11,12). The oilier 
complexion and higher androgen levels are believed 
to be the cause. A study conducted in Nottingham 
shows that only 22% of the adolescence had talked 
to a doctor in regards to their acne. There is clearly a 
difference in the health seeking behavior among gender, 
whereby only 42% of the male patients in comparison 
to 70% of the female patients had talked to a friend 
about skin problem (13). Thus, male patients typically 
seek help only when their acne is easily noticeable. 
Furthermore, females were found to be experiencing 
more embarrassment due to acne (14,15), which leads 
to earlier dermatology consultation. 
Figure 2: Frequency of psychological symptoms in according to 
severity
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A study on acne disability index among patients who 
attended dermatology outpatient clinic in Sarawak (8) 
found a mean CADI score of 5.1± 3.83, which is lower 
than our study.  This can probably be explained by the 
fact that our study have more patients with moderate 
acne severity. The difference observed can probably 
due to demographic and socio-economic background 
differences (16,17). However, in comparison with 
community based studies (11,12,21), hospital based 
studies (8,19) have shown significant higher amount 
of disability. This might be due to the fact that patients 
who sought treatment in specialist dermatology clinics 
may have more psychological distress in view of their 
condition even before the consultation (8). The hospital 
based study typically target young adults, while the 
community based study are mainly adolescents or 
late adolescents. Young adulthood entails significant 
transition. Path such as college, employment, 
relationship, marriage may be involved during this 
transition, in which each has its own implication. It 
was found that almost half of the lifetime diagnosable 
problems present by the age of 14 while nearly three 
quarters of the symptoms of lifetime problems started by 
the age of 24 (18). This age difference may have cause 
the difference in functional disability index. Overall, the 
impact of acne on quality of life or functional disability 
is very hard to compare, as majority of the studies 
have different questionnaire design, study setting and 
population characteristic (19). 
CADI assess the perception of aggression, social life 
interference, public changing amenities avoidance, 
skin appearance and self-perceived acne severity. The 
least affected components were social life interference 
and public changing amenities avoidance, in which 
our patients scored 1.29 ± 1.00 and 0.84 ± 1.10 each. 
This finding is consistent with 2 other studies conducted 
in Malaysia (8,11). A French based study on school 
pupils with acne revealed that only 20% of the pupils 
have their personal and social life affected and only 
10% avoided swimming and other sports because of 
embarrassment (20). Similar findings were found in 
a Nigerian based study (21). It had been postulated 
that this may either suggest that extra-facial acne is 
uncommon, or such lesion have no effect on patients 
using the public changing facilities, or even because 
the vast majority of respondents may not need public 
changing facilities as they don’t participate in outdoor 
activities (21). Although acne is common, it is mainly 
of mild severity (11,12,19,21).  The prevalence and the 
mild severity may explain why acne doesn’t interfere 
much with social life.
It is found that 31% of the dermatology patients has 
psychiatric morbidity, in comparison with general 
population (22). Thus, it is crucial to screen for this 
symptoms among our dermatology patients. DASS-21 
is widely use to screen for symptoms of depression, 
anxiety and stress in community setting. Its’ positive 
result need further proper psychiatric evaluation 
before a final diagnosis could be given. According to 
Diagnostic and Statistical Manual of Mental Disorders 
(Fifth Edition), major depressive disorder is defined as 
having severely depressed mood that persist for at least 2 
weeks. Generalized anxiety disorder is characterized by 
worry for most days for at least 6 months. In our study, 
about 70% of the patients are screened positive for 
anxiety, while less than 50% of the patients are screened 
positive for depression and stress. However, further 
proper psychological evaluation is needed to confirm 
the diagnosis. There is no significant relationship found 
between anxiety, depression and stress with gender and 
severity of acne. A cross-sectional study in Iran, showed 
an anxiety prevalence of 68.3% while the prevalence of 
depression was found to be 25.6% (23). Our study has 
comparable prevalence of anxiety, but higher reported 
depression symptoms in comparison to this Iranian 
study. Our study shows a huge difference in comparison 
with other studies conducted (24-26) which shows an 
anxiety rate of 24.7% to 38.4%, while depression rate 
range from 13.3% to 29.5%. The possible explanation 
is the use of different acne severity scales and anxiety, 
depression screening tool. A study using DASS-21 
and Hospital Anxiety Depression Scale (HADS) in 
rheumatoid arthritis patients have found near similar 
anxiety mean score in between both groups while 
higher mean depression score in patients who answered 
to DASS-21 (27). It might be also because of the socio-
economic, cultural and climatic differences that have 
attributed to the different coping mechanisms to deal 
with the diseases. 
Stress is rather poorly researched in patients with acne 
vulgaris. In our study, we have found almost 40% of 
patients reported stress symptoms. As this is a cross-
sectional study, it is rather impossible for us to correlate 
if this is related to acne vulgaris. However, neuroimaging 
has demonstrated the presence of substance P receptor 
on sebaceous gland and the production of sebum is 
increased when this receptor is activated (28). It has 
been speculated that stress could upregulate sebum 
production via this receptor, which cause acne vulgaris 
flare (6). Thus, if stress is not properly addressed, the 
control of acne vulgaris might not be satisfactory. 
However, further study is needed to confirm this 
postulation. 
In our study, CADI is found to be significantly related 
with depression (p=0.012), anxiety (p= 0.015) and 
stress (p=0.001), which is a not surprising finding, as 
psychological symptoms are frequently related with 
functional disability (20). Though both are related, each 
sets of questionnaires measure different aspect and thus 
both sets of questionnaires should be used in future 
studies. 
Oral isotretinoin is approved by the United States Food 
& Drug Administration (FDA) for treatment of severe 
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as well as psychological comorbidities and should not 
be taken lightly. It is suggested that physicians who 
are treating acne vulgaris should take the opportunity 
to screen for psychological symptoms and refer to the 
respective team if necessary. Treatment for acne shall 
not be solely based on severity, but should be tapered 
in accordance its effect on functional disability and 
psychological impact as well.  
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